Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aclarion, Inc. stock logo
ACONW
Aclarion
$0.04
-0.3%
$0.03
$0.01
$0.24
N/AN/A32,070 shs1,200 shs
American Oncology Network, Inc. stock logo
AONC
American Oncology Network
$11.51
+3.0%
$11.66
$2.10
$14.25
N/AN/A2,968 shs6,840 shs
DHACW
Digital Health Acquisition
$0.04
$0.04
$0.01
$0.40
N/AN/A71,147 shsN/A
Psychemedics Corporation stock logo
PMD
Psychemedics
$2.67
$2.52
$1.63
$3.25
$16.31MN/AN/A113,627 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aclarion, Inc. stock logo
ACONW
Aclarion
0.00%-29.09%+18.98%+7.01%+15.84%
American Oncology Network, Inc. stock logo
AONC
American Oncology Network
-2.78%+1.08%+9.07%+39.75%+205.46%
DHACW
Digital Health Acquisition
0.00%+0.39%-53.62%-30.43%-56.90%
Psychemedics Corporation stock logo
PMD
Psychemedics
0.00%0.00%0.00%0.00%+17.11%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aclarion, Inc. stock logo
ACONW
Aclarion
N/AN/AN/AN/AN/AN/AN/AN/A
American Oncology Network, Inc. stock logo
AONC
American Oncology Network
N/AN/AN/AN/AN/AN/AN/AN/A
DHACW
Digital Health Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Psychemedics Corporation stock logo
PMD
Psychemedics
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aclarion, Inc. stock logo
ACONW
Aclarion
0.00
N/AN/AN/A
American Oncology Network, Inc. stock logo
AONC
American Oncology Network
0.00
N/AN/AN/A
DHACW
Digital Health Acquisition
0.00
N/AN/AN/A
Psychemedics Corporation stock logo
PMD
Psychemedics
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aclarion, Inc. stock logo
ACONW
Aclarion
$62.95KN/AN/AN/AN/AN/A
American Oncology Network, Inc. stock logo
AONC
American Oncology Network
$1.34BN/AN/AN/AN/AN/A
DHACW
Digital Health Acquisition
N/AN/AN/AN/AN/AN/A
Psychemedics Corporation stock logo
PMD
Psychemedics
$19.68M0.83N/AN/A$0.84 per share3.18
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aclarion, Inc. stock logo
ACONW
Aclarion
N/AN/A0.00N/AN/AN/AN/AN/A
American Oncology Network, Inc. stock logo
AONC
American Oncology Network
N/AN/A0.00N/AN/AN/AN/AN/A
DHACW
Digital Health Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
Psychemedics Corporation stock logo
PMD
Psychemedics
-$1.86M-$0.51N/AN/A-9.26%-32.32%-18.53%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aclarion, Inc. stock logo
ACONW
Aclarion
N/AN/AN/AN/AN/A
American Oncology Network, Inc. stock logo
AONC
American Oncology Network
N/AN/AN/AN/AN/A
DHACW
Digital Health Acquisition
N/AN/AN/AN/AN/A
Psychemedics Corporation stock logo
PMD
Psychemedics
N/AN/AN/AN/A1 Years
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aclarion, Inc. stock logo
ACONW
Aclarion
N/AN/AN/A
American Oncology Network, Inc. stock logo
AONC
American Oncology Network
N/AN/AN/A
DHACW
Digital Health Acquisition
N/AN/AN/A
Psychemedics Corporation stock logo
PMD
Psychemedics
0.01
1.82
1.82

Institutional Ownership

CompanyInstitutional Ownership
Aclarion, Inc. stock logo
ACONW
Aclarion
N/A
American Oncology Network, Inc. stock logo
AONC
American Oncology Network
N/A
DHACW
Digital Health Acquisition
N/A
Psychemedics Corporation stock logo
PMD
Psychemedics
32.07%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aclarion, Inc. stock logo
ACONW
Aclarion
7N/AN/ANot Optionable
American Oncology Network, Inc. stock logo
AONC
American Oncology Network
1,520N/AN/ANot Optionable
DHACW
Digital Health Acquisition
N/AN/AN/ANot Optionable
Psychemedics Corporation stock logo
PMD
Psychemedics
1406.11 million5.26 millionNot Optionable

Recent News About These Companies

Psychemedics Releases 2025 Workforce Insights Report
Phoenix Molecular Designs Launches Phase II Trial in RSK2-High Breast Cancer
Psychemedics announces reverse stock split, forward stock split
Psychemedics reminds stockholders to cast votes for Annual Meeting
Psychemedics Reports Improved Losses Amid Revenue Dip
Psychemedics Corporation (PMD)

Media Sentiment Over Time

Aclarion stock logo

Aclarion NASDAQ:ACONW

$0.04 0.00 (-0.28%)
As of 08/26/2025 12:23 PM Eastern

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

American Oncology Network stock logo

American Oncology Network NASDAQ:AONC

$11.51 +0.33 (+2.97%)
As of 02:48 PM Eastern

American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.

Digital Health Acquisition NASDAQ:DHACW

$0.04 0.00 (0.00%)
As of 08/27/2025

Digital Health Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on technology and healthcare focused businesses. Digital Health Acquisition Corp. was incorporated in 2021 and is based in Boca Raton, Florida.

Psychemedics stock logo

Psychemedics NASDAQ:PMD

Psychemedics Corporation, together with its subsidiaries, engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opioids, such as heroin metabolite, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, fentanyl and fentanyl analogs, and alcohol. The company's testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. It offers its services to employers for job applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. The company was incorporated in 1986 and is headquartered in Dallas, Texas.